Ardeschir G.
- Country
- Germany
- Department
- Universitaetsklinikum Giessen und Marburg GmbHPneumologie,Nephrologie und Gastroenterologie
Research Overview
- Long-term Safety and Efficacy Evaluation of Inhaled Seralutinib in WHO Group 1 Pulmonary Arterial Hypertension
- Long-term Evaluation of Sotatercept in Combination with Background Therapy for Pulmonary Arterial Hypertension in Adult Patients
- Evaluation of Sotatercept Plus Background Therapy Versus Placebo in Intermediate- and High-risk Pulmonary Arterial Hypertension: A Phase 3 Randomized Study
Data & Insights
Has run more than one trial at 67 of 98 partner sites.
Specializations
Pulmonary Arterial Hypertension Management
This investigator specializes in studying innovative treatments for Pulmonary Arterial Hypertension (PAH), with particular focus on evaluating novel therapeutic agents like seralutinib and sotatercept.
- WHO Group 1 PAH Treatment
- Long-term Disease Management
- High-risk PAH Patient Care
Research activities encompass both newly diagnosed and advanced-stage PAH patients requiring specialized therapeutic interventions.
Advanced Pulmonary Hypertension Research
The investigator conducts studies in complex forms of pulmonary hypertension, including Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) associated with heart conditions.
- Heart Failure with Preserved Ejection Fraction
- Pulmonary Vascular Resistance Assessment
- Exercise Capacity Evaluation
Focus extends to investigating therapeutic solutions for patients with complicated cardiovascular comorbidities.
Clinical Safety and Efficacy Studies
Expertise in conducting comprehensive evaluations of novel therapeutic agents, with emphasis on long-term safety profiles and treatment tolerability in pulmonary hypertension.
- Biomarker Analysis
- Treatment Response Monitoring
- Extended Duration Safety Assessment
Research includes monitoring of clinical outcomes and disease progression markers in various patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.